Valuation (24%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.44 | 14.31 |
| PEG Ratio (TTM) | -0.05 | -4.80 |
| P/S Ratio (TTM) | 0.14 | 2.16 |
| P/B Ratio (TTM) | 0.12 | 6.09 |
| P/FCF Ratio (TTM) | -5.98 | 20.82 |
| Price to 5YR AVG Earnings Ratio | N/A | 26.09 |
| Price to 5YR AVG FCF Ratio | N/A | 29.04 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -14.45% | 9.28% |
| ROE (TTM) | -24.16% | 40.46% |
| Net Profit Margin (TTM) | -32.18% | 13.43% |
| ROIC 5YR AVG | N/A | 14.83% |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 0.29% | -543.76% | N/A |
| Revenue | -4.16% | 19.17% | N/A |
| Net Income | -0.36% | -620.37% | N/A |
| Cash Flow | -29.73% | -29.58% | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.24 | 2.28 |
| Quick Ratio (TTM) | 1.41 | 1.80 |
| D/E Ratio (TTM) | 0.48 | 2.05 |
| Interest Coverage (TTM) | -2.17 | 14.63 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | N/A | 3.45 |
| LTL to 5YR AVG FCF | N/A | 7.13 |
| Shares Outstanding Growth 5YR AVG | N/A | -2.07% |